iwNHL 2015: Duvelisib, dual inhibitor of PI3K delta and PI3K gamma, for indolent non-Hodgkin lymphoma

At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Ian Flinn, MD, of Tennessee Oncology, Nashville, TN, discusses the clinical development of duvelisib, a dual inhibitor of ph... Author: VJHemOnc Added: 11/22/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts